19 results match your criteria: "Mayo Clinic Children's Research Center[Affiliation]"
J Child Adolesc Psychopharmacol
December 2024
Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.
J Child Adolesc Psychopharmacol
December 2024
Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.
J Child Adolesc Psychopharmacol
November 2024
Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.
J Child Adolesc Psychopharmacol
October 2024
Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.
J Child Adolesc Psychopharmacol
September 2024
Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
J Child Adolesc Psychopharmacol
August 2024
Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, MN, USA.
J Child Adolesc Psychopharmacol
June 2024
Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.
J Child Adolesc Psychopharmacol
May 2024
Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.
J Child Adolesc Psychopharmacol
April 2024
Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.
J Child Adolesc Psychopharmacol
March 2024
Professor of Pediatrics, Pharmacology, and Psychiatry, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.
Brain Behav
March 2024
Department of Psychiatry and Psychology, Mayo Clinic Children's Research Center, and Mayo Clinic Depression Center, Mayo Clinic, Rochester, Minnesota, USA.
Introduction: Invasive neuromodulation interventions such as deep brain stimulation (DBS) and vagal nerve stimulation (VNS) are important treatments for movement disorders and epilepsy, but literature focused on young patients treated with DBS and VNS is limited. This retrospective study aimed to examine naturalistic outcomes of VNS and DBS treatment of epilepsy and dystonia in children, adolescents, and young adults.
Methods: We retrospectively assessed patient demographic and outcome data that were obtained from electronic health records.
Biol Psychiatry Cogn Neurosci Neuroimaging
March 2024
Ervin A. and Margaret C. Mueller Mayo Clinic Children's Research Center, Departments of Psychiatry, Psychology, Pediatrics and Pharmacology, Mayo Clinic, Rochester, Minnesota. Electronic address:
J Child Adolesc Psychopharmacol
December 2023
Department of Psychiatry, Pharmacology, and Pediatrics, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.
J Child Adolesc Psychopharmacol
November 2023
Professor of Psychiatry, Pharmacology, and Pediatrics, Ervin A. and Margaret C. Mueller Director, Mayo Clinic Children's Research Center, Mayo Clinic, Rochester, Minnesota, USA.
J Child Adolesc Psychopharmacol
November 2023
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Parents frequently purchase and inquire about smartwatch devices to monitor child behaviors and functioning. This pilot study examined the feasibility and accuracy of using smartwatch monitoring for the prediction of disruptive behaviors. The study enrolled children ( = 10) aged 7-10 years hospitalized for the treatment of disruptive behaviors.
View Article and Find Full Text PDFMethods Enzymol
May 2018
Mayo Clinic, Rochester, MN, United States; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, United States; Mayo Clinic Children's Research Center, Rochester, MN, United States. Electronic address:
Although Fe-S clusters may assemble spontaneously from elemental iron and sulfur in protein-free systems, the potential toxicity of free Fe, Fe, and S ions in aerobic environments underscores the requirement for specialized proteins to oversee the safe assembly of Fe-S clusters in living cells. Prokaryotes first developed multiprotein systems for Fe-S cluster assembly, from which mitochondria later derived their own system and became the main Fe-S cluster suppliers for eukaryotic cells. Early studies in yeast and human mitochondria indicated that Fe-S cluster assembly in eukaryotes is centered around highly conserved Fe-S proteins (human ISCU) that serve as scaffolds upon which new Fe-S clusters are assembled from (i) elemental sulfur, provided by a pyridoxal phosphate-dependent cysteine desulfurase (human NFS1) and its stabilizing-binding partner (human ISD11), and (ii) elemental iron, provided by an iron-binding protein of the frataxin family (human FXN).
View Article and Find Full Text PDFJ Biol Chem
September 2016
From the Departments of Pediatric and Adolescent Medicine and Biochemistry Molecular Biology, Mayo Clinic Children's Research Center, and
Fe-S clusters, essential cofactors needed for the activity of many different enzymes, are assembled by conserved protein machineries inside bacteria and mitochondria. As the architecture of the human machinery remains undefined, we co-expressed in Escherichia coli the following four proteins involved in the initial step of Fe-S cluster synthesis: FXN (iron donor); [NFS1]·[ISD11] (sulfur donor); and ISCU (scaffold upon which new clusters are assembled). We purified a stable, active complex consisting of all four proteins with 1:1:1:1 stoichiometry.
View Article and Find Full Text PDFJ Biol Chem
May 2016
From the Departments of Pediatric and Adolescent Medicine and Biochemistry and Molecular Biology, and the Mayo Clinic Children's Research Center, and
The biosynthesis of Fe-S clusters is a vital process involving the delivery of elemental iron and sulfur to scaffold proteins via molecular interactions that are still poorly defined. We reconstituted a stable, functional complex consisting of the iron donor, Yfh1 (yeast frataxin homologue 1), and the Fe-S cluster scaffold, Isu1, with 1:1 stoichiometry, [Yfh1]24·[Isu1]24 Using negative staining transmission EM and single particle analysis, we obtained a three-dimensional reconstruction of this complex at a resolution of ∼17 Å. In addition, via chemical cross-linking, limited proteolysis, and mass spectrometry, we identified protein-protein interaction surfaces within the complex.
View Article and Find Full Text PDF